Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Starch × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Head & Neck 2 Gastrointestinal 2 Lymphoid 1 Gynecologic 1 Breast 1

Conditions

Gastrointestinal Toxicity 1

Interventions

Paclitaxel 578 Carboplatin 527 Cisplatin 355 Bevacizumab 254 pembrolizumab 223 Gemcitabine 153 olaparib 130 liposomal doxorubicin 130 Topotecan 128 Cyclophosphamide 125 Radiotherapy 118 Taxes 115 Docetaxel 95 Brachytherapy 94 Drug Therapy 90 niraparib 88 Doxorubicin 86 Surveys and Questionnaires 84 Magnetic Resonance Spectroscopy 79 Blood Specimen Collection 72 Nivolumab 70 Specimen Handling 69 Hyperthermic Intraperitoneal Chemotherapy 64 Biopsy 63 fludarabine 55 Filgrastim 53 Letrozole 50 Oxaliplatin 49 durvalumab 47 Immunoglobulin G 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02351089 2020-03-05

ProRad

Probi AB

Phase NA Terminated

GastrointestinalGynecologic

Gastrointestinal Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡